43% of new cases are in three states of Maharashtra, Andhra Pradesh and Karnataka

▴ 43% of new cases are in three states of Maharashtra, Andhra Pradesh and Karnataka
Nearly half of active cases are only from 3 states

Seven States have contributed to 70% of these new cases in the last 24 hours. Of these, Maharashtra has contributed the maximum case load amounting to almost 21%, followed by Andhra Pradesh (13.5%), Karnataka (11.27%) and Tamil Nadu which stands at 8.27%.

Uttar Pradesh with 8.27%, West Bengal with 3.85%, and Odisha with 3.84% are the remaining States contributing to the increased caseload. Of the total cumulative number of cases, 43% are recorded in just three states of Maharashtra, Andhra Pradesh and Karnataka.

While Tamil Nadu has contributed 11.66% of the total cases. Maharashtra, Andhra Pradesh and Karnataka account for about 50% of the deaths added in the last 24 hours due to COVID-19, with Maharashtra leading with 30.48%.The Union Government yesterday said that the COVID-19 recovery rate in the country has reached 76.61 per cent. Around 60,868 people recovered from the infection during the last 24 hours.

The Health Ministry said, the total number of recoveries has reached over 27 lakh 74 thousand so far.

The Ministry said, the last five lakh recoveries have been recorded in only eight days.

The constantly increasing recoveries have ensured reduction in the actual caseload of the country and it now comprises only 21.60 per cent of the total positive cases.Currently, India’s Case Fatality Rate is at 1.79 per cent, which is one of the lowest globally.

According to Indian Council of Medical Research, over 8,46000 tests were conducted during the last 24 hours. The total number of samples tested so far has gone up to over 4 crore 23 lakhs.

Meanwhile,  Japan has committed an official Development Assistance loan of 3500 crore rupees for the COVID-19 Crisis Emergency Response Support. The Notes were exchanged between the Additional Secretary in the Department of Economic Affairs Dr C.S. Mohapatra and Ambassador of Japan to India Suzuki Satoshi for a Health sector programme loan to fight the COVID-19 crisis.

Subsequent to the Exchange of Notes, Loan Agreement for the programme loan was signed between Dr Mohapatra and Chief Representative of JICA in New Delhi Katsuo Matsumoto.

Japan International Cooperation Agency, JICA is a governmental agency that coordinates Official Development Assistance for the Government of Japan.

This programme loan aims to support India’s efforts in fighting COVID-19 and to prepare the health system to manage future epidemics and also to improve the resilience of India’s health systems against infectious diseases.

Notes were also exchanged between Dr. Mohapatra and Mr Satoshi for Grant Assistance of 70 crore rupees from the Government of Japan.

This Grant-in-aid from the Government of Japan is for providing medical equipment to strengthen the public health and medical system in India. It will strengthen the health care facilities for managing critical and serious patients suffering from COVID-19 infection.

India and Japan have had a long and fruitful history of bilateral development cooperation since 1958. In the last few years, the economic cooperation between India and Japan has strengthened and grown into strategic partnership. It further consolidates and strengthens the Strategic and Global Partnership between India and Japan.

Tags : #IndiaNewCovidCases #JapanCovidAssistance #IndiaCovidNewsUpdateSep1 #IndiaCovidStatusSep1 #JICA #CaseFatalityRate #SuzukiSatoshi

About the Author


Team Medicircle

Related Stories

12 Nov

Sanofi completes acquisition of Kadmon

Latest pharma news updates

View
20 Sep

Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

Latest pharma news update

View
05 Aug

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics

Corporate Pharma news upedat

View
17 Jul

LabGenius announces research collaboration with Ablynx, a Sanofi Company

Latest pharma update : Research and Collaboration

View
16 Jul

Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science

Latest FDA approvals update

View
14 Jul

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources and efforts where we can bring the most value, especially to consumers.

View
09 Jul

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a second stage will evaluate a second formulation targeting the Beta variant (B.1.351)

View
28 Apr

Moderna announces agreement with Sanofi for manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Moderna and Sanofi collaborate for covid vaccine manufacturing

View
18 Mar

ProBioGen licenses GlymaxX Technology to Sanofi

GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)

View
15 Feb

Sanofi's mRNA vaccine would not be available this year ; CEO

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025